<DOC>
	<DOCNO>NCT02086799</DOCNO>
	<brief_summary>This study explore whether supplementation thyroid hormone set-up asthma exacerbation could improve clinical outcome . The study include adult admit Rambam health care campus moderate severe Asthma exacerbation . The study prospective , randomize , double-blind , placebo-controlled , clinical trial . Patients randomized admission receive treatment intra-venous thyroxine ( 100mcg admission additional 100mcg 12 hour ) placebo . The study treatment give initial bronchodilator therapy , oxygen informed consent give . The primary endpoint time return peak expiratory flow ( PEF ) rate normal value personal base line .</brief_summary>
	<brief_title>Thyroid Hormones Treatment Asthma Exacerbation</brief_title>
	<detailed_description>Study population : The study include adult admit Internal Medicine B ( IMB ) department , Internal Medicine H ( IMH ) department medical intensive care unit ( MICU ) Rambam-Health Care Campus moderate severe Asthma exacerbation . The severity exacerbation base several acceptable clinical laboratory criterion , include breathless , alertness , pulse rate , respiratory rate , partial pressure oxygen arterial blood ( PaO2 ) , partial pressure carbon dioxide arterial blood ( PaCO2 ) , oxygen saturation , peak expiratory flow ( PEF ) . Study protocol : The study prospective , randomize , double-blind , placebo-controlled , clinical trial . Patients randomized admission receive treatment intra-venous thyroxine ( 100mcg admission additional 100mcg 12 hour ) placebo . The study treatment give initial bronchodilator therapy , oxygen informed consent give . The primary endpoint time return PEF rate normal value personal base line . PEF rate examine first initial bronchodilator therapy , every 8 hour .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>18 year age old Known Asthma The exacerbation define moderate severe . Not currently enrol active participant another clinical trial medical therapy device . The patient first degree family relative ( case patient intubate ) authorize his/her consent participate trial . The patient ask give consent initial bronchodilator therapy 60 year age old Known thyroid disorder Subject thyrotoxicosis suspect Known heart disease Heart rate &gt; 140</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>asthma</keyword>
	<keyword>thyroid hormone</keyword>
	<keyword>treatment</keyword>
	<keyword>asthma exacerbation</keyword>
</DOC>